NCT03033537View on ClinicalTrials.gov

Intracavernosal Injection of Papaverine/Verapamil Versus Papaverine/Phentolamine in Erectile Dysfunction

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

July 1, 2015

Primary Completion Date

January 1, 2016

Study Completion Date

January 20, 2016

Conditions
Erectile Dysfunction
Interventions
DRUG

Verapamil

Local treatment of erectile dysfunction

Sponsors
All Listed Sponsors
lead

Adam International Hospital

OTHER

NCT03033537 - Intracavernosal Injection of Papaverine/Verapamil Versus Papaverine/Phentolamine in Erectile Dysfunction | Biotech Hunter | Biotech Hunter